109685 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Adenoviral vectors comprising partial deletions of E3
#302MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS
#303Virus
#304LYSIS, EXTRACTION AND PURIFICATION OF ADENO-ASSOCIATED VIRUS AND ADENOVIRUS FROM HOST CELLS
#305Oncolytic adenoviruses for treating cancer
#306Viral vector assay and vector
#307Stable, spray dried, immunogenic, viral compositions
#308GENE DELIVERY SYSTEM CONTAINING RELAXIN GENE AND PHARMACEUTICAL COMPOSITION USING RELAXIN
#309PV-DELETED BOVINE ADENOVIRUS
#310Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens
#311Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#312Antiviral vaccines with improved cellular immunogenicity
#313Immunogenic compositions and uses thereof
#314Gene Therapy For Mesothelioma
#315Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays
#316Adenovirus polynucleotides and polypeptides
#317Conjugates of IL13Rα2 binding agents and use thereof in cancer treatment
#318Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#319Adeno-associated-virus Rep sequences, vectors and viruses
#320Compositions and methods for mitochondrial genome editing
#321Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)
#322Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#323Methods of treating cancer
#324Potent and balanced bidirectional promoter
#325Vaccine composition
#326Interferon Therapy
#327Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
#328Tumor-specific adenovirus vectors and therapeutic uses
#329Vaccine composition
#330Adenovectors for delivery of therapeutic genetic material into T cells
#331Adenovirus armed with bispecific T cell engager
#332Potent and balanced bidirectional promoter
#333Methods and compositions for inducing protective immunity against a marburg virus infection
#334METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#335Adenovirus and immunomodulator combination therapy
#336Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager
#337Hepatitis B virus (HBV) vaccines and uses thereof
#338ONCOLYTIC ADENOVIRUSES FOR CANCER TREATMENT
#339Adenoviral vector
#340Prime target
#341Targeting PD-L1 on tumor cells
#342Compositions and methods of replication deficient adenoviral vectors for vaccine applications
#343Methods and compositions for performing continuous directed evolution
#344Method of providing safe administration of adenoviral vectors encoding a zika virus antigen
#345Recombinant adenoviruses and use thereof
#346Tumor-selective E1a and E1b mutants
#347COMBINATION THERAPY WITH CPG TLR9 LIGAND
#348Methods of transdifferentiation and methods of use thereof
#349PRODUCTION OF VIRAL VECTORS
#350COMPOSITIONS AND METHODS FOR TUMOR VACCINATION USING PROSTATE CANCER-ASSOCIATED ANTIGENS
#351Substitutions-modified prefusion RSV F proteins and their use
#352Method for delivery of biological molecule to nervous tissue
#353Single cycle replicating adenovirus vectors
#354Oncolytic adenovirus encoding a B7 protein or active fragment
#355Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#356Composition for treating HBV infection
#357Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
#358Enhanced thermal stability for adenoviral vectors through spray drying
#359Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#360Use of adenovirus and nucleic acids coding therefor
#361Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor
#362Treatment of heart disease by inhibtion of the action of muscle A-kinase anchoring protein (mAKAP)
#363Recombinant adenoviruses carrying transgenes
#364Vectors for expression of prostate-associated antigens
#365Compositions and methods for viral delivery of neoepitopes and uses thereof
#366Viral vector targeting cancer stem cells
#367Vectors Conditionally Expressing Protein
#368Cell populations, methods of transdifferentiation and methods of use thereof
#369Engineered Cells Expressing Multiple Immunomodulators and Uses Thereof
#370Immunogenic compositions and uses thereof
#371Prefusion RSV F proteins and their use
#372METHODS OF USE OF INHIBITORS OF PHOSPHODIESTERASES AND MODULATORS OF NITRIC OXIDE, REACTIVE OXYGEN SPECIES, AND METALLOPROTEINASES IN THE TREATMENT OF PEYRONIE'S DISEASE, ARTERIOSCLEROSIS AND OTHER FIBROTIC DISEASES
#373Methods and compositions for gene inactivation
#374CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
#375Oncolytic adenoviruses armed with heterologous genes
#376Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmid
#377Ebola virus disease vaccine taking human replication deficient adenovirus as vector
#378Methods for inducing an immune response
#379Composition for diagnosing, preventing, or treating vascular smooth muscle cell proliferative diseases using FGF12
#380POLYNUCLEOTIDES FOR TREATING ONCOGENIC VIRAL POLYPEPTIDE POSITIVE TUMORS
#381Influenza vaccines
#382Potent and short promoter for expression of heterologous genes
#383Method for propagating adenoviral vectors encoding inhibitory gene products
#384Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
#385Adenoviral vector encoding human atonal homolog-1 (HATH1)
#386Compositions and methods to modulate cell activity
#387Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#388Methods and compositions for combination immunotherapy
#389Cancer specific-splicing ribozyme and use thereof
#390Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#391Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#392Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#393Adenovirus polynucleotides and polypeptides
#394Formulations for small intestinal delivery of RSV and norovirus antigens
#395Stable, Spray Dryed, Immunogenic, Viral Compositions
#396Compositions and methods for treating cancer
#397Oncolytic adenovirus encoding a B7 protein
#398Recombinant adenovirus expressing two transgenes with a bidirectional promoter
#399Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#400IL13Rα2 binding agents and use thereof in cancer treatment
#401Immunomodulatory fusion proteins
#402Immunization of avians by administration of non-replicating vectored vaccines
#403Immune modulator for immunotherapy and vaccine formulation
#404THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER
#405ADENOVIRAL TUMOR DIAGNOSTICS
#406Modified serotype 28 adenoviral vectors
#407Therapeutic gene cocktail for heart regeneration
#408Mosaic chimeric viral vaccine particle
#409Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same
#410Canine adenovirus vectors
#411Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
#412METHODS AND COMPOSITIONS FOR ENHANCING CARDIAC CONTRACTILITY FOR TREATMENT OF HEART FAILURE
#413Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#414Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#415Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
#416Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#417Systems, methods and compositions for optical stimulation of target cells
#418Oncolytic adenovirus encoding a B7 protein
#419Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#420METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#421Stable, Spray Dryed, Immunogenic, Viral Compositions
#422Method of treating type I diabetes using an AAV vector encoding uracortin 2
#423Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#424Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
#425Use of adenovirus and nucleic acids coding therefor
#426Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#427Multitargeting onocolytic adenovirus, methods of use, and methods of making
#428Methods of inducing responsiveness to anti-angiogenic agent
#429CMV glycoproteins and recombinant vectors
#430MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES
#431Vaccination methods
#432Immunization agents and methods of use
#433Poxviral vaccines
#434ADENOVIRUS CONSTRUCTS AND METHODS
#435Sequence arrangements and sequences for neoepitope presentation
#436Engineered Dendritic Cells and Uses for the Treatment of Cancer
#437Anti-cancer compositions containing Wnt decoy receptor
#438Oncolytic adenovirus encoding a therapeutic protein or active fragment
#439Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#440Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#441Antiviral vaccines with improved cellular immunogenicity
#442Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#443Genetic indicator and control system and method utilizing split Cas9/CRISPR domains for transcriptional control in eukaryotic cell lines
#444Interferon therapy
#445High isomerohydrolase activity mutants of human RPE65
#446CpG reduced factor VIII variants, compositions and methods and uses for treatment of hemostasis disorders
#447Animal models, cell lines and methods for screening hepatitis C virus vaccines
#448Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#449Treatment and prevention of malaria
#450Production of viral vectors
#451ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
#452Method and compositions
#453Factor involved in latent infection with herpes virus, and use thereof
#454CD40 ligand fusion protein vaccine
#455Adenoviral vectors comprising partial deletions of E3
#456Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
#457Replication defective adenovirus vector in vaccination
#458Immunogenic combinations
#459SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#460Compositions and methods for the detection or treatment of uterine leiomyosarcoma
#461HPV vaccines and methods of use thereof
#462Adenoviral vector vaccine
#463Breast cancer vaccines and methods of use thereof
#464Adenoviral vector-based vaccine against enterovirus infection
#465Oncolytic adenovirus encoding a B7 protein or active fragment
#466Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#467Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#468Adenovirus comprising an albumin-binding moiety
#469Chimpanzee adenoviral vector-based filovirus vaccines
#470Group B adenovirus modified in the E4orf4 region
#471Cancer Therapy
#472Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#473METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS
#474Compositions and methods to promote wound healing
#475Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#476Polynucleotides for treating oncogenic viral polypeptide positive tumors
#477Oncolytic adenoviruses for cancer treatment
#478Polynucleotides, vectors and methods for insertion and expression of transgenes
#479Oncolytic adenoviruses armed with heterologous genes
#480METHODS AND COMPOSITIONS FOR GENE INACTIVATION
#481Compositions and methods for targeting stromal cells for the treatment of cancer
#482Immunity enhancing therapeutic vaccine for HPV and related diseases
#483Method of making adenovirus and corresponding plasmids
#484Immunomodulatory compositions and methods of use thereof
#485METHOD FOR PROPAGATING ADENOVIRAL VECTORS ENCODING INHIBITORY GENE PRODUCTS
#486Immunogenic compositions and uses thereof
#487Compositions and methods for cardiac regeneration
#488Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#489Puma protein expression vector and use thereof in gene therapy
#490Vectors for expression of prostate-associated antigens
#491Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
#492Method of making induced pluripotent stem cells
#493Method to kill pathogenic microbes in a patient
#494Methods of transdifferentiation and methods of use thereof
#495Methods and compositions for increased transgene expression
#496ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#497Stable aqueous formulations of adenovirus vectors
#498Method for optically controlling a neuron with a mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from natromonas pharaonis (NpHR)
#499Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#500Method of suppressing gene transcription through histone lysine methylation
#501Cell populations, methods of transdifferentiation and methods of use thereof
#502Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#503Methods of inducing responsiveness to anti-angiogenic agent
#504Tripartite cancer theranostic nucleic acid constructs
#505Vaccine composition
#506Adenoviral vector encoding human atonal homolog-1 (HATH1)
#507MODIFIED ADENOVIRUS HEXON PROTEIN AND USES THEREOF
#508Replication-competent adenoviral vectors
#509Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#510Replication defective adenovirus vector in vaccination
#511Use of adenoviruses and nucleic acids that code for said viruses
#512Prefusion RSV F proteins and their use
#513Antiviral vaccines with improved cellular immunogenicity
#514Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
#515Adeno-associated-virus Rep sequences, vectors and viruses
#516Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#517SIMIAN ADENOVIRUS NUCLEIC ACID AND AMINO ACID SEQUENCES, VECTORS CONTAINING SAME, AND METHODS OF USE
#518Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#519Methods of propagating monkey adenoviral vectors
#520Immune modulator for immunotherapy and vaccine formulation
#521Oncolytic adenovirus armed with therapeutic genes
#522Adenovirus vectors
#523Recombinant adenoviruses and use thereof
#524Replicating recombinant adenovirus vectors, compositions, and methods of use thereof
#525NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES
#526Modified serotype 28 adenoviral vectors
#527Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
#528Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#529Vectors for expression of prostate-associated antigens
#530Endothelial cell-specific polynucleotides and use thereof
#531Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
#532Compositions and methods
#533Long lasting drug formulations
#534Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
#535Nucleic acid construct and use of the same
#536Methods of cytotoxic gene therapy to treat tumors
#537Simian adenovirus 41 and uses thereof
#538Methods for generating immunity to antigen
#539Chimeric adenoviruses for use in cancer treatment
#540Adenoviruses and their use
#541Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
#542LPL variant therapeutics
#543Polynucleotides for treating oncogenic viral polypeptide positive tumors
#544Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
#545Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
#546Complementing cell lines
#547Adenoviral tumor diagnostics
#548Adenoviruses expressing heterologous tumor-associated antigens
#549Stable aqueous formulations of adenovirus vectors
#550Anti-cancer compositions containing WNT decoy receptor
#551Simian (gorilla) adenovirus or adenoviral vectors and methods of use
#552Vectors conditionally expressing protein
#553CMV glycoproteins and recombinant vectors
#554Method for propagating adenoviral vectors encoding inhibitory gene products
#555Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
#556Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#557Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#558Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
#559Production of viral vectors
#560Method of vaccination comprising a histone deacetylase inhibitor
#561Vaccine against RSV
#562Constructs for making induced pluripotent stem cells
#563Uniform field magnetization and targeting of therapeutic formulations
#564Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
#565REIC-expressing adenovirus vector
#566Vaccine against RSV
#567Lipoparticles comprising proteins, methods of making, and using the same
#568Methods and compositions for gene inactivation
#569Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#570Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR)
#571Vaccine and drug delivery by intranasal application of vector and vector extracts
#572Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#573Compositions and methods for targeting stromal cells for the treatment of cancer
#574Adenoviral expression vector encoding a CD40L fusion protein
#575Batches of recombinant adenovirus with altered terminal ends
#576Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#577Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#578Immunization of avians by administration of non-replicating vectored vaccines
#579Adenoviral vector-based dengue fever vaccine
#580Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
#581Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#582Compositions and methods for retargeting virus constructs
#583HSV-1 epitopes and methods for using same
#584Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#585Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells
#586Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
#587Long lasting drug formulations
#588Chimeric adenoviruses for use in cancer treatment
#589Sequential administration of a replication defective adenovirus vector in vaccination protocols
#590Chimeric adenoviruses for use in cancer treatment
#591Heterologous prime boost vaccination regimen against malaria
#592Chimeric adenoviruses for use in cancer treatment
#593Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#594Adenovirus vaccine vectors
#595Chimeric adenoviral vectors
#596Uniform field magnetization and targeting of therapeutic formulations
#597Engineered dendritic cells and uses for the treatment of cancer
#598Compositions, kits and methods for treatment of complement-related disorders
#599Factor involved in latent infection with herpesvirus, and use thereof
#600Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein